Publications

HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.

Nair, N; Moss, WJ; SCOTT, S; Mugala, N; Ndhlovu, ZM; Lilo, K; Ryon, JJ; Monze, M; Quinn, TC; COUSENS, S; CUTTS, F; Griffin, DE;

2009

The Journal of infectious diseases, (2009).200 7 10.1086/605648.

Complex cytokine profiles induced by BCG vaccination in UK infants.

Lalor, MK; SMITH, SG; FLOYD, S; GORAK-STOLINSKA, P; Weir, RE; BLITZ, R; BRANSON, K; FINE, PE; DOCKRELL, HM;

2009

Vaccine, (2009).28 6 10.1016/j.vaccine.2009.11.004.

Landscape analysis of interactions between nutrition and vaccine responses in children.

Savy, M; EDMOND, K; FINE, PE M; Hall, A; HENNIG, BJ; MOORE, SE; MULHOLLAND, K; Schaible, U; PRENTICE, AM;

2009

The Journal of nutrition, (2009).139 11 10.3945/jn.109.105312.

Developing sustainable funding for vaccine safety infrastructure.

Black, S; MULHOLLAND, K; Halsey, NA;

2009

Vaccine, (2009).28 5 10.1016/j.vaccine.2009.11.034.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien, KL; Wolfson, LJ; Watt, JP; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; MULHOLLAND, K; Levine, OS; Cherian, T; Hib and Pneumococcal Global Burden of Disease Stud,;

2009

Lancet, (2009).374 9693 10.1016/S0140-6736(09)61204-6.

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Watt, JP; Wolfson, LJ; O'Brien, KL; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; Levine, OS; Hajjeh, R; MULHOLLAND, K; Cherian, T; Hib and Pneumococcal Global Burden of Disease Stud,;

2009

Lancet, (2009).374 9693 10.1016/S0140-6736(09)61203-4.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Walker, LM; Phogat, SK; Chan-Hui, P-Y; Wagner, D; Phung, P; Goss, JL; Wrin, T; Simek, MD; Fling, S; Mitcham, JL; Lehrman, JK; Priddy, FH; Olsen, OA; Frey, SM; Hammond, PW; Protocol G Principal Investigators,; Kaminsky, S; Zamb, T; Moyle, M; Koff, WC; Poignard, P; Burton, DR;

2009

Science (New York, NY), (2009).326 5950 10.1126/science.1178746.

Do we still need a malaria vaccine?.

GREENWOOD, B; TARGETT, G;

2009

Parasite immunology, (2009).31 9 10.1111/j.1365-3024.2009.01140.x.

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.

Waitumbi, JN; Anyona, SB; Hunja, CW; Kifude, CM; Polhemus, ME; Walsh, DS; Ockenhouse, CF; Heppner, DG; Leach, A; Lievens, M; Ballou, WR; Cohen, JD; SUTHERLAND, CJ;

2009

PloS one, (2009).4 11 10.1371/journal.pone.0007849.

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.

Sirima, SB; Tiono, AB; Ouédraogo, A; Diarra, A; Ouédraogo, AL; Yaro, JB; Ouédraogo, E; Gansané, A; Bougouma, EC; Konaté, AT; Kaboré, Y; Traoré, A; Chilengi, R; Soulama, I; Luty, AJ F; Druilhe, P; COUSENS, S; Nébié, I;

2009

PloS one, (2009).4 10 10.1371/journal.pone.0007549.